Phenylephrine Hydrochloride Injection 10 mg/mL Solution for injection.
PDF Leaflet Revision Date: 05 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
For increasing blood pressure in adults with hypotension from vasodilation.
Dosage (summary)
Dilute before administration; 50-250 mcg IV bolus or 0.5-6 mcg/kg/min continuous infusion.
Onset of Action / Duration
Onset: minutes, Duration: short-lived
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy; small amounts excreted in breast milk.
Key Drug Interactions
- Non-selective MAO inhibitors
- Dopaminergic agents
- Tricyclic antidepressants
Contraindications
- Hypersensitivity
- Uncontrolled hypertension
- Severe cardiac failure
Common side effects
- Bradycardia
- Hypertension
- Nausea
- Vomiting
Counselling Points
- Monitor for side effects
- Avoid extravasation
- Gradually reduce dosage when discontinuing
Serious warnings
- Risk of ischemic gangrene
- Monitor blood pressure
- Caution in patients with coronary artery disease
Important Disclaimer
The Phenylephrine Hydrochloride Injection 10 mg/mL Solution for injection. professional information leaflet below is the property of Abbott Laboratories Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
